Clinical Trials Logo

Clinical Trial Summary

Left ventricular systolic dysfunction (LVSD) refers to impaired contraction of the left ventricle, and can lead to heart failure and death. Early identification of LVSD, which often remains asymptomatic for years, is therefore crucial to mitigate the associated risks through appropriate treatment. Echocardiographic screening of asymptomatic individuals is costly, requires access to experts, and the criteria for selecting potential high-risk individuals for screening remain unclear. Unlike echocardiography, the electrocardiogram (ECG) is a relatively low-cost procedure, routinely available and requiring little technical training to set up the examination and collect data, making it an interesting tool for early detection of LVSD.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06163911
Study type Observational
Source Central Hospital, Nancy, France
Contact
Status Not yet recruiting
Phase
Start date December 1, 2023
Completion date June 1, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05975567 - Deploying Novel Imaging Modalities Towards a Three-dimensional (3D) CARDIOvascular PATHology
Recruiting NCT04950218 - The Psoriasis Echo Study
Recruiting NCT01414179 - NESCAV Nutrition Environment and Cardiovascular Health N/A
Completed NCT01275963 - New Echocardiographic Parameters for Assessment of Longitudinal Left Ventricular Function N/A
Completed NCT04598685 - Early Vascular Ageing in the YOUth
Completed NCT06319417 - Hydroxytyrosol Caramel Treatment on Cardiovascular Risk Patients N/A